DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.
DXA
bone quality
bone strain index
finite element analysis
fractures
primary hyperparathyroidism
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
13 07 2021
13 07 2021
Historique:
received:
02
12
2020
pubmed:
9
5
2021
medline:
21
10
2021
entrez:
8
5
2021
Statut:
ppublish
Résumé
Primary hyperparathyroidism (PHPT) is associated with impaired bone quality and increased fracture risk. Reliable tools for the evaluation of bone quality parameters are not yet clinically available. Bone Strain Index (BSI) is a new metric for bone strength based on Finite Element Analysis from lumbar spine and femoral neck dual-energy x-ray absorptiometry (DXA) images. To assess the lumbar spine (LS), femoral neck (FN), and total hip (TH) BSI in PHPT patients compared with controls and to investigate the association of BSI with vertebral fractures (VFs) in PHPT. This case-control study enrolled 50 PHPT patients and 100 age- and sex-matched control subjects from an outpatient clinic. The main outcome measures were LS-BSI, FN-BSI, and TH-BSI. FN bone mineral density (BMD) and one-third distal radius BMD were lower in the PHPT group than in controls (FN 0.633 ± 0.112 vs 0.666 ± 0.081, P = 0.042; radius 0.566 ± 0.07 vs 0.625 ± 0.06, P < 0.001). PHPT group has significant lower TBS score compared with controls (1.24 ± 0.09 vs 1.30 ± 0.10, P < 0.001). BSI was significantly higher at LS (2.28 ± 0.59 vs 2.02 ± 0.43, P = 0.009), FN (1.72 ± 0.41 vs 1.49 ± 0.35, P = 0.001), and TH (1.51 ± 0.33 vs 1.36 ± 0.25, P = 0.002) in PHPT. LS-BSI showed moderate accuracy for discriminating VFs (AUC 0.667; 95% CI, 0.513-0.820). LS-BSI ≥ 2.2 and was a statistically significant independent predictor of VFs, with an adjusted odds ratio ranging from 5.7 to 15.1. BSI, a DXA-derived bone quality index, is impaired in PHPT and may help to identify PHPT subjects at high risk of fractures.
Identifiants
pubmed: 33963754
pii: 6272395
doi: 10.1210/clinem/dgab317
pmc: PMC8599893
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2304-2312Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Haemophilia. 2018 Nov;24(6):980-987
pubmed: 30273987
PLoS One. 2019 Dec 5;14(12):e0225905
pubmed: 31805121
Front Bioeng Biotechnol. 2019 Sep 10;7:220
pubmed: 31552243
Osteoporos Int. 2021 Jun;32(6):1053-1060
pubmed: 33527175
Ann Intern Med. 2016 Jun 7;164(11):715-23
pubmed: 27043778
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):553-61
pubmed: 25166047
Eur J Endocrinol. 2013 Jun 29;169(2):155-62
pubmed: 23682095
Front Med (Lausanne). 2021 Jan 15;7:590139
pubmed: 33521014
PLoS One. 2018 Jan 5;13(1):e0190477
pubmed: 29304151
Osteoporos Int. 1994 Nov;4(6):368-81
pubmed: 7696835
PLoS One. 2020 Mar 11;15(3):e0229820
pubmed: 32160208
Nat Rev Dis Primers. 2016 May 19;2:16033
pubmed: 27194212
J Clin Densitom. 2019 Apr - Jun;22(2):162-170
pubmed: 30093271
Metabolism. 2018 Mar;80:57-65
pubmed: 29051042
Bone Rep. 2018 Aug 09;9:101-109
pubmed: 30116767
J Clin Densitom. 2013 Jan-Mar;16(1):28-32
pubmed: 23374738
Lancet. 2018 Jan 13;391(10116):168-178
pubmed: 28923463
J Biomech. 2003 Jul;36(7):897-904
pubmed: 12757797
J Bone Miner Res. 2013 May;28(5):1029-40
pubmed: 23225022
Nat Rev Endocrinol. 2018 Feb;14(2):115-125
pubmed: 28885621
Rev Endocr Metab Disord. 2021 Dec;22(4):789-802
pubmed: 33200346
Front Horm Res. 2019;51:13-22
pubmed: 30641522
J Bone Miner Res. 1993 Sep;8(9):1137-48
pubmed: 8237484
South Med J. 2008 Jul;101(7):735-9
pubmed: 18580720
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1512-1521
pubmed: 29373705
J Clin Densitom. 2021 Apr-Jun;24(2):330-337
pubmed: 33199190
Arch Osteoporos. 2018 Aug 27;13(1):93
pubmed: 30151698
J Clin Endocrinol Metab. 2008 Sep;93(9):3462-70
pubmed: 18544625
Osteoporos Int. 2021 Jan;32(1):85-91
pubmed: 32936366
J Clin Endocrinol Metab. 2020 Jan 1;105(1):
pubmed: 31588503
PLoS One. 2021 Feb 8;16(2):e0245967
pubmed: 33556061
Bone. 2013 Mar;53(1):154-9
pubmed: 23228370
Eur J Endocrinol. 2006 Sep;155(3):415-20
pubmed: 16914595
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
pubmed: 25162665
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
JAMA. 2020 Mar 24;323(12):1186-1187
pubmed: 32031566
J Endocrinol Invest. 2018 Nov;41(11):1339-1348
pubmed: 29616419
Acta Endocrinol (Buchar). 2018 Apr-Jun;14(2):208-212
pubmed: 31149259
J Clin Endocrinol Metab. 2013 May;98(5):1963-70
pubmed: 23526463
Calcif Tissue Int. 2020 Dec;107(6):551-558
pubmed: 32839841
Curr Osteoporos Rep. 2020 Jun;18(3):103-114
pubmed: 32222892
J Clin Endocrinol Metab. 2018 Jan 1;103(1):196-205
pubmed: 29069380
Osteoporos Int. 2006 Feb;17(2):281-9
pubmed: 16172798
World J Surg. 2003 Mar;27(3):343-9
pubmed: 12607064